Adult patients with Laron syndrome tend to develop the metabolic syndrome.

Cardiovascular disease Diabetes Dyslipidemia IGF-I deficiency Laron syndrome Metabolic syndrome Obesity

Journal

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
ISSN: 1532-2238
Titre abrégé: Growth Horm IGF Res
Pays: Scotland
ID NLM: 9814320

Informations de publication

Date de publication:
25 Jul 2024
Historique:
received: 18 06 2024
accepted: 22 06 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 31 7 2024
Statut: aheadofprint

Résumé

The metabolic Syndrome is the name of a cluster of abnormal clinical and metabolic states, which constitute a risk factor for diabetes and cardiovascular disease. To determine whether adult patients with Laron Syndrome with excessive obesity develop the characteristics of the Metabolic Syndrome. Out of a cohort of adult patients with Laron Syndrome followed in our clinic, records of 23 patients (12 females, 11 males) were found to have sufficient data for analysis. The degree of obesity was determined by the measurement of subscapular skinfold thickness (SSFT), BMI and total body DEXA. NAFLD was determined by liver ultrasonography, serum lipids including adiponectin leptin, insulin and glucose were assessed by radioimmunoassay. Both female and male patients were markedly obese with 59% and 39% fat of the total body mass respectively, as were total and LDL cholesterol, triglycerides and adiponectin. Some had developed NAFLD. They also suffered from insulin resistance and glucose intolerance. Eleven patients (3 females, 8 males) developed diabetes. All had varying degrees of hypertension. Eight subjects (3 females, 5 males) suffered from cardiovascular disease. One female died at aged 53 years, and two males died at ages 75 and 78 years. With advancing age and increasing obesity, adult patients with Laron Syndrome developed the characteristics of Metabolic Syndrome including diabetes and cardiovascular disease.

Sections du résumé

BACKGROUND BACKGROUND
The metabolic Syndrome is the name of a cluster of abnormal clinical and metabolic states, which constitute a risk factor for diabetes and cardiovascular disease.
AIM OBJECTIVE
To determine whether adult patients with Laron Syndrome with excessive obesity develop the characteristics of the Metabolic Syndrome.
SUBJECTS METHODS
Out of a cohort of adult patients with Laron Syndrome followed in our clinic, records of 23 patients (12 females, 11 males) were found to have sufficient data for analysis.
METHODS METHODS
The degree of obesity was determined by the measurement of subscapular skinfold thickness (SSFT), BMI and total body DEXA. NAFLD was determined by liver ultrasonography, serum lipids including adiponectin leptin, insulin and glucose were assessed by radioimmunoassay.
RESULTS RESULTS
Both female and male patients were markedly obese with 59% and 39% fat of the total body mass respectively, as were total and LDL cholesterol, triglycerides and adiponectin. Some had developed NAFLD. They also suffered from insulin resistance and glucose intolerance. Eleven patients (3 females, 8 males) developed diabetes. All had varying degrees of hypertension. Eight subjects (3 females, 5 males) suffered from cardiovascular disease. One female died at aged 53 years, and two males died at ages 75 and 78 years.
CONCLUSION CONCLUSIONS
With advancing age and increasing obesity, adult patients with Laron Syndrome developed the characteristics of Metabolic Syndrome including diabetes and cardiovascular disease.

Identifiants

pubmed: 39084176
pii: S1096-6374(24)00035-2
doi: 10.1016/j.ghir.2024.101605
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101605

Informations de copyright

Copyright © 2023. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have nothing to declare.

Auteurs

Zvi Laron (Z)

Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center, Tel Aviv University, Israel. Electronic address: Laronz@clalit.org.il.

Rivka Kauli (R)

Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center, Tel Aviv University, Israel.

Avivah Silbergeld (A)

Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center, Tel Aviv University, Israel.

Classifications MeSH